News for Healthier Living

Medicaid Enrollees with Diabetes Lack Access to Medications with Cardiovascular Health Benefits

A national cross-sectional study evaluated the unrestricted availability of sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the only two diabetes medications that reduce cardiovascular disease (CVD) and death, among Medicaid enrollees.

April 21, 2025


May 2 2025

May 1 2025

April 30 2025

April 29 2025

April 28 2025

April 27 2025

April 26 2025

April 25 2025

April 24 2025

April 23 2025

April 22 2025

April 21 2025

April 19 2025

April 18 2025